Integrating Genetic Insights, Technological Advancements, Screening, and Personalized Pharmacological Interventions...

Area of Science:

• Pediatric Endocrinology
• Genetics
• Public Health

Background:

• Childhood obesity prevalence has surged globally over 50 years, impacting immediate and long-term health.
• Estimated 206 million children and adolescents aged 5-19 will have obesity by 2025.
• Rising rates in both girls (0.7% to 5.6%) and boys (0.9% to 7.8%) underscore the epidemic's urgency.

Purpose of the Study:

• To explore the intricate relationship between genomics, genetics, and epigenetics in pediatric obesity.
• To review advancements in omics technologies and their application to understanding obesity.
• To discuss the evolutionary basis of adiposity and hyperphagia in the context of genetic factors.

Main Methods:

• Comprehensive literature review focusing on genetic and epigenetic influences in pediatric obesity.
• Analysis of current and emerging omics technologies, including genotyping.
• Examination of evolutionary perspectives on adiposity and hyperphagia.

Main Results:

• Genomic and genetic factors, including monogenic and polygenic forms, play a significant role in pediatric obesity.
• Epigenetic modifications are increasingly recognized as crucial in obesity development.
• Advancements in genotyping technologies provide novel insights into genetic predispositions.

Conclusions:

• Integrating genetic screening into clinical practice is vital for early identification of at-risk children.
• Personalized treatment strategies informed by genetic profiles can improve outcomes for pediatric obesity.
• Understanding the genetic architecture of obesity is key to developing effective interventions.